Skip to main content
Premium Trial:

Request an Annual Quote

AstraZeneca Extends License for Linguamatics Text-Mining Software

NEW YORK, Dec. 19 (GenomeWeb News) - AstraZeneca has extended its license for Linguamatics' text-mining software, the natural language processing company said today.

 

AstraZeneca signed the original license agreement in October 2003 to use the technology for its drug discovery and development programs.

 

Linguamatics' interactive text-mining system, I2E, analyzes research literature and other text. The company said that it partners with BioWisdom's Intelligence Network to enhance its search performance over other text-mining approaches.

 

No financial details of the deal were disclosed.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.